Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beclin-1 is a scaffolding protein crucial for initiating autophagy in mammalian cells, encoded by the BECN1 gene in humans[1][5]. It is the mammalian ortholog of yeast Atg6, and interacts with class III phosphoinositide 3-kinase (PI3K) complexes and Bcl-2 family proteins to regulate both autophagy and apoptosis[1][3][5]. Structurally, Beclin-1 contains an N-terminal intrinsically disordered region (with a Bcl-2 homology 3/BH3 domain), a central coiled-coil domain that mediates protein interactions, and a C-terminal evolutionarily conserved (BARA/ECD) domain with membrane-binding properties crucial for autophagic function[1][2][3]. Beclin-1 serves as a hub for membrane trafficking and signal integration, orchestrating the formation and maturation of autophagosomes by recruiting and regulating key autophagy proteins such as VPS34, VPS15, UVRAG, and ATG14[1][3]. It is implicated in multiple disease processes—including cancer (as a haploinsufficient tumor suppressor), neurodegenerative disorders, and inflammation—largely due to its central role in maintaining cellular homeostasis by promoting proper turnover of cellular components and regulating cell death[3][5]. Loss or mutation of Beclin-1 is associated with increased tumor development, impaired autophagy, and defective cellular clearance pathways[5].
Induction of autophagy via increased Beclin-1 expression or activity, Modulation of protein-protein interactions in the autophagy machinery
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beclin-1 (Beclin1).